| Authors: |
Haddad FG; MD Anderson Cancer Center, Department of Leukemia, The University of Texas, Houston, TX. Electronic address: fhaddad@mdanderson.org., Jabbour E; MD Anderson Cancer Center, Department of Leukemia, The University of Texas, Houston, TX., Sasaki K; MD Anderson Cancer Center, Department of Leukemia, The University of Texas, Houston, TX., Black S; Department of Internal Medicine, Baylor College of Medicine, Houston, TX., Savoy JM; MD Anderson Cancer Center, Department of Leukemia, The University of Texas, Houston, TX., Alvarado Y; MD Anderson Cancer Center, Department of Leukemia, The University of Texas, Houston, TX., Borthakur G; MD Anderson Cancer Center, Department of Leukemia, The University of Texas, Houston, TX., Pemmaraju N; MD Anderson Cancer Center, Department of Leukemia, The University of Texas, Houston, TX., Yilmaz M; MD Anderson Cancer Center, Department of Leukemia, The University of Texas, Houston, TX., Delasalla S; MD Anderson Cancer Center, Department of Leukemia, The University of Texas, Houston, TX., Issa GC; MD Anderson Cancer Center, Department of Leukemia, The University of Texas, Houston, TX., Kantarjian H; MD Anderson Cancer Center, Department of Leukemia, The University of Texas, Houston, TX. |
